
TELA Bio, Inc. — Investor Relations & Filings
TELA Bio, Inc. is a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions. The company designs, develops, and markets a portfolio of products engineered to leverage a patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. Its core product line, the OviTex® Reinforced Tissue Matrix, combines layers of ovine (sheep) rumen with interwoven polymer sutures. This technology is designed to offer strength and facilitate tissue remodeling with a lower foreign body footprint than traditional synthetic mesh. TELA Bio's products are used in a variety of surgical procedures, including hernia repair, abdominal wall reconstruction, and plastic and reconstructive surgery.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - TELA Bio, Inc. (0001561921) (Filer) | 2026-04-30 | English | |
| S-8 - TELA Bio, Inc. (0001561921) (Filer) | 2026-03-25 | English | |
| 8-K - TELA Bio, Inc. (0001561921) (Filer) | 2026-03-20 | English | |
| 4 - TELA BIO, INC. (0001561921) (Filer) | 2026-02-25 | English | |
| 4 - TELA BIO, INC. (0001561921) (Filer) | 2026-02-25 | English | |
| 4 - TELA BIO, INC. (0001561921) (Filer) | 2026-02-25 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
9 filings
| |||||
| 39227978 | ARS - TELA Bio, Inc. (0001561921) (Filer) | 2026-04-30 | English | ||
| 33042839 | S-8 - TELA Bio, Inc. (0001561921) (Filer) | 2026-03-25 | English | ||
| 33001987 | 8-K - TELA Bio, Inc. (0001561921) (Filer) | 2026-03-20 | English | ||
| 32893947 | 4 - TELA BIO, INC. (0001561921) (Filer) | 2026-02-25 | English | ||
| 32893946 | 4 - TELA BIO, INC. (0001561921) (Filer) | 2026-02-25 | English | ||
| 32893949 | 4 - TELA BIO, INC. (0001561921) (Filer) | 2026-02-25 | English | ||
| 32893950 | 4 - TELA BIO, INC. (0001561921) (Filer) | 2026-02-25 | English | ||
| 32893948 | 4 - TELA BIO, INC. (0001561921) (Filer) | 2026-02-25 | English | ||
| 32893951 | 4 - TELA BIO, INC. (0001561921) (Filer) | 2026-02-25 | English | ||
|
2025
6 filings
| |||||
| 12598996 | 424B3 | 2025-12-23 | English | ||
| 12598997 | Regulatory Filings 2025 | 2025-12-19 | English | ||
| 12598998 | S-3 | 2025-12-12 | English | ||
| 12598999 | Major Shareholding Notification 2025 | 2025-11-17 | English | ||
| 12599000 | Director's Dealing 2025 | 2025-11-17 | English | ||
| 12599001 | FORM 8-K | 2025-11-14 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of medical and dental instruments and supplies
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
3-D Matrix,Ltd.
Develops peptide-based hydrogels to control bleeding in sur…
|
7777 | JP | Manufacturing |
|
aap Implantate AG
Develops, manufactures, and markets implants for the treatm…
|
AAQ1 | DE | Manufacturing |
|
ABATE AS INDUSTRIES LIMITED
Manufactures therapeutic footwear and wellness products for…
|
531658 | IN | Manufacturing |
|
Acotec Scientific Holdings Limited
Interventional medical device company developing innovative…
|
6669 | KY | Manufacturing |
|
AcouSort AB
Develops acoustofluidic solutions for automated biological …
|
ACOU | SE | Manufacturing |
|
Adagio Medical Holdings, Inc.
Develops cryoablation technologies for treating cardiac arr…
|
ADGM | US | Manufacturing |
|
ADVANCED MEDICAL SOLUTIONS GROUP PLC
Develops and manufactures innovative tissue-healing technol…
|
AMS | GB | Manufacturing |
|
AETHLON MEDICAL INC
Develops immunotherapeutic devices to deplete exosomes and …
|
AEMD | US | Manufacturing |
|
Affluent Medical
Develops minimally invasive implants for structural heart d…
|
AFME | FR | Manufacturing |
|
Aidite (Qinhuangdao) Technology Co., Ltd.
Develops and manufactures dental materials, zirconia cerami…
|
301580 | CN | Manufacturing |
TELA Bio, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34422/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34422 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34422 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34422 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34422}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TELA Bio, Inc. (id: 34422)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.